Fortress Biotech, Inc. (FBIOP) Total liabilities 2016–2025
Fortress Biotech, Inc. (FBIOP) total liabilities at each fiscal year-end, per SEC filings.
$123.4MFY2025 · since FY2016: $87.8M → $123.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $123.4M | -15.4% |
| FY2024 | $145.9M | -12.1% |
| FY2023 | $165.9M | -32.1% |
| FY2022 | $244.3M | +43.2% |
| FY2021 | $170.6M | +25.1% |
| FY2020 | $136.4M | -11.4% |
| FY2019 | $153.9M | +26.9% |
| FY2018 | $121.3M | -3.3% |
| FY2017 | $125.4M | +42.9% |
| FY2016 | $87.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More FBIOP financial trends
FBIOP RevenueFBIOP Net incomeFBIOP Net marginFBIOP Gross profitFBIOP Gross marginFBIOP Operating incomeFBIOP Operating marginFBIOP Operating cash flowFBIOP Free cash flowFBIOP Capital expendituresFBIOP Return on equityFBIOP Stock buybacksFBIOP Dividends paidFBIOP Total assetsFBIOP Shareholders’ equityFBIOP overview →